Lance Willsey
Independent Chairman of the Board of DirectorDr. Lance Willsey, M. D, M. S. serves as Independent Director at EDAP TMS S. A. since December 6, 2023 and also serves as its Independent Chairman of the Board of Director since September 2024. He had been Independent Director of Exelixis, Inc. since April 1997 until May 8, 2023. He was a Founding Partner of DCF Capital from July 1998 to April 2002. From July 1997 to July 1998, Dr. Willsey served on the Staff Department of Urologic Oncology, Dana Farber Cancer Institute at Harvard University School of Medicine. From July 1996 to July 1997, he served on the Staff Department of Urology, Massachusetts General Hospital at Harvard University School of Medicine. He served as a Director of Exact Sciences Corp. from May 2000 to July 2010. Since 2000, Dr. Willsey has served on the Visiting Committee of the Department of Genitourinary Oncology at the Dana-Farber Cancer Institute at Harvard Medical School. From July 1997 to July 1998, Dr. Willsey served on the Staff Department of Urologic Oncology at the Dana-Farber Cancer Institute. Dr. Willsey holds B. S. in Physiology from Michigan State University and an M. S. in Biology and an M. D. both from Wayne State University.
Positions
- Company NameEDAP TMS S.A.Stock CodeFOCLPositionIndependent Chairman of the Board of DirectorColleagues
- RRRyan RhodesCEO & Director
- KMKenneth MobeckChief Financial Officer
- SASteven AnnenExecutive Vice President of Marketing & Product Management
- CECarre EmmanuelChief Operating Officer
- FDFrancois DietschChief Accounting Officer
- FDFrances D. SchulzIndependent Director
- JHJoshua H. LevineIndependent Director
- DRDavid R. HornDirector
